"The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
Orbactiv is approved to treat patients with acute bacterial skin and skin structure infections (ABSS"...
DOSAGE AND ADMINISTRATION
LoKara™ Lotion (desonide lotion 0.05%) should be applied to the affected areas as a thin film two or three times daily depending on the severity of the condition.
SHAKE WELL BEFORE USING.
As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary.
LoKara™ Lotion (desonide lotion 0.05%) should not be used with occlusive dressings.
LoKara™ Lotion (desonide lotion 0.05%) is supplied in bottles as follows:
59 mL (2 fl oz) NDC 0462-0392-02
118 mL (4 fl oz) NDC 0462-0392-04
Store between 2° and 30°C (36° and 86°F).
PharmaDerm a division of Altana Inc., Norcross, GA 30093 USA. Revised 3/03This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 9/27/2011
Additional LoKara Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.